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The fungus Cryptococcus neoformans is a leading
cause of mortality and morbidity among HIV-infected
individuals. We utilized the completed genome se-
quence and optimized methods for homologous
DNA replacement using high-velocity particle bom-
bardment to engineer 1201 gene knockout mutants.
We screened this resource in vivo for proliferation
in murine lung tissue and in vitro for three well-recog-
nized virulence attributes—polysaccharide capsule
formation, melanization, and growth at body temper-
ature. We identified dozens of previously uncharac-
terized genes that affect these known attributes as
well as 40 infectivity mutants without obvious defects
in these traits. The latter mutants affect predicted
regulatory factors, secreted proteins, and immune-
related factors, and represent powerful tools for
elucidating novel virulence mechanisms. In particu-
lar, we describe a GATA family transcription factor
that inhibits phagocytosis by murine macrophages
independently of the capsule, indicating a previously
unknown mechanism of innate immune modulation.
INTRODUCTION
Systematic profiling of gene deletion strain collections has been
essential for the comprehensive study of biological processes in
the nonpathogenic yeast Saccharomyces cerevisiae (Bader
et al., 2003). Likewise, forward genetic screens of large mutant
collections of bacterial pathogens have been extremely fruitful
in identifying virulence pathways in prokaryotic organisms
(Saenz and Dehio, 2005). In contrast, the study of fungal patho-
genesis has historically been hindered by a relative lack of
genetic tools and techniques in these eukaryotic species. With
the release of complete genome sequences for numerous fungal
pathogens (Jones et al., 2004; Loftus et al., 2005; Nierman et al.,
2005), there are now unprecedented opportunities to create174 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.genome-scale resources and to apply systematic methods to
the study of fungal virulence.
Cryptococcus neoformans is the most common cause of
systemic fungal infections in people infected with HIV (Bicanic
and Harrison, 2004). Whereas primary pulmonary infections are
typically mildly symptomatic and self-resolving in patients with
intact immune systems, these infections commonly disseminate
through the bloodstream to infect the meninges in HIV-positive
patients. In sub-Saharan Africa and Southeast Asia, where
over 80% of the world’s HIV-infected population lives, studies
indicate that 10%–40% of HIV-related deaths are caused by
cryptococcal meningitis (Corbett et al., 2002; French et al.,
2002). The high cost and limited availability of antifungal drugs
often prohibit effective medical treatment in these areas (War-
nock, 2006) and mortality rates in parts of sub-Saharan African
approach 100% (Bekondi et al., 2006).
There are three well-established mediators of C. neoformans
virulence: a polysaccharide capsule, cell wall-associated mela-
nin, and the ability to grow at human body temperature. The
capsule has been shown to have both antiphagocytic and immu-
nomodulatory properties (Del Poeta, 2004; Monari et al., 2006).
Melanin is believed to protect the fungus from a broad range of
toxic insults, both in the environment and the host (Nosanchuk
and Casadevall, 2003).
Molecular studies of C. neoformans virulence pathways have
focused almost exclusively on the regulation of capsule andmel-
anization (Table S1 available online). Attempts to identify novel
virulence mechanisms using random insertional mutagenesis
have been hampered by biases in the insertion sites, chromo-
somal rearrangements, and relatively low ORF hit rates (Idnurm
et al., 2004; Nelson et al., 2001). The release of the complete
C. neoformans genome sequence now makes it possible to
use directed gene knockout mutants to screen for novel viru-
lence mechanisms. To this end, we constructed a large library
of 1201 signature-tagged, targeted gene deletion strains. Below,
we describe insights gained from systematic profiling of this
library in a murine infection model and in three in vitro assays
for virulence-associated attributes (Figure 1). We also describe
detailed analysis of a key transcriptional regulator that has
pointed to the existence of an unsuspected capsule-indepen-
dent mechanism for inhibition of phagocytosis.
RESULTS
Generation of Signature-Tagged C. neoformans
Gene Deletion Collection
Approximately 1500 genes in C. neoformans were targeted for
deletion by homologous recombination. The majority (900)
were selected because of the absence of obvious homologs in
the nonpathogenic fungus S. cerevisiae. The remainder encode
proteins with sequencemotifs implicating them in a broad variety
of cellular processes. Because these targets were chosen prior
to the availability of detailed gene models and were based on
BLAST-based annotations (Chow et al., 2007), there was
a bias against genes that areC. neoformans-specific. We utilized
fusion PCR to create deletion constructs in a high-throughput
manner and optimized biolistic transformation for efficient re-
combination. For reasons described below, each mutant strain
contains one of 48 unique signature tag DNA sequences adja-
cent to the deletion marker. The resulting set of 1201 verified
mutants represents deletions of 1180 genes (in some cases,
different domains of the same gene were targeted separately).
For comparison, the genome of C. neoformans is predicted to
contain 6,500 genes (Loftus et al., 2005), and 190 targeted
gene deletions in C. neoformans have previously been reported
in the literature (Table S1). The deletion collection is currently
Figure 1. Schematic Overview of System-
atic Phenotypic Profiling Strategy Utilized
in This Work
available without restriction through the
Fungal Genetic Stock Center (www.
fgsc.org) or ATCC (www.atcc.org).
Quantitative Screen for Infectivity
Mutants in a Murine Inhalation
Model of Disease
To identify C. neoformans genes involved
in infectivity, we adopted signature-
tagged mutagenesis (STM), a strategy
that enables high-throughput, parallel
analysis of pathogen mutants in experi-
mental infections (Saenz and Dehio,
2005). In this method, individual mutants
aremarked in their genomeswith a unique
DNA sequence (termed a signature tag or
a barcode). This allows a pool of many
mutants to be tested in a single animal
infection by comparing the relative repre-
sentation of each mutant in the pool
before and after selection in the host. In
practice, this is accomplished by isolat-
ing DNA frommutant pathogen pools be-
fore and after infection and quantifying
the abundance of each tag in the sample.
We developed a robust, quantitative
STM assay utilizing a previously estab-
lishedmousemodel of pulmonary crypto-
coccal infection (Cox et al., 2000). C. neoformans deletion
mutants were grown independently and then pooled into groups
of 48 for intranasal infection of mice. Infections were allowed to
progress until the mice displayed signs of significant morbidity
(5–6 weeks), at which time the mice were sacrificed and
C. neoformans cells were recovered from the lung tissue. Quan-
titative PCR using tag-specific primers together with a common
primer in the gene deletion cassette was used to measure the
relative abundance of each mutant in both the input and recov-
ered pools. The ratio of these two values ([recovered] / [input])
was calculated on a log2 scale and termed the STM score (see
Experimental Procedures). As shown in Figure 2A, STM scores
demonstrated remarkable consistency among the three mice
infected with each pool of signature-tagged mutants. In total,
1100 deletion mutants were screened using the STM assay.
We next determined if the STM score for a given mutant was
affected by the composition of mutants in that pool. 104mutants
were removed from their original pools and sorted into new pools
containing different mutants. Infections were repeated and STM
scores were recalculated for each mutant. The original STM
scores were highly correlated with the re-pooled STM scores
(R2 = 0.84), demonstrating that the STM scores were largely
independent of the identities of the competing mutants and
were highly reproducible from pool to pool (Figure 2B).Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 175
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As an additional control for reproducibility of the assay, we
constructed 43 independent disruptions of the gene SXI1, which
is required for mating but dispensable for virulence (Hull et al.,
2004); each mutant was marked with a different signature tag.
The 43 sxi1D mutant strains were tested a total of 293 times
throughout the STM screen and, as expected, the distribution
of STM scores for the sxi1D strains was centered near zero
(median = 0.1) and showed a tight range (SD = 0.5) (Figure 2C).
The distribution of STM scores for the deletion library as a whole
was also centered on zero (median = 0.0); however, in this case,
the distribution of scores wasmuch broader (SD = 3.3), suggest-
ing a wide range of fitness in the assay.
STM Phenotypes Correlate with Virulence
STM screens are designed to measure the relative competitive
fitness of mutants in a mixed infection. Thus, the term ‘‘infectiv-
ity’’ in this context refers to this ability to proliferate/survive within
host tissue. ‘‘Virulence,’’ on the other hand, is classically defined
as the ability of an individual strain not only to proliferate, but to
cause disease as well. To assess the ability of our STM screen
phenotypes to predict virulence defects, we performed two
additional tests.
First, we asked whether previously identified virulence
mutants included in our deletion collection were detected by
the screen. Among 24 previously-reported virulence mutants,
21 displayed STM scores significantly below zero, ranging
from 12.8 to 1.9 (labeled on the x axis of Figure 2C and Table
S2). Two published virulence mutants, lac1D and ure1D, had
normal STM scores. These mutants, however, are known to
replicate normally in mouse lungs and have late defects in
dissemination (Noverr et al., 2004; Olszewski et al., 2004); such
mutants would not be anticipated to have defects in our screen.
The final virulence mutant, scp1D, was retested in our assay
using a different pool of mutants, and a significantly lower STM
score was detected (3.6 versus 0.8). These results demon-
strate a robust sensitivity of the STM screen for virulence genes
known to affect propagation in pulmonary tissue (21 mutants
identified of 22 mutants with known lung defects). Conversely,
the sxi1D STM data described above did not yield a single neg-
ative outlier and all seven mutants in the collection containing
deletions of genes known to be dispensable for virulence had
normal STM scores suggesting a screen specificity for infectivity
defects approaching 100% (Figure 2C, Table S2).
In a second test, we conducted classical time-to-endpoint
survival analyses for seven previously-uncharacterized mutantswith awide range of STM scores. In these experiments, virulence
was directly measured by determining the rate at which mice
infected with a single strain of C. neoformans reach a defined
disease endpoint (see Supplemental Data). Monotypic intranasal
infections of 8–10 mice per mutant and a wild-type control were
performed and the time to significant morbidity was assessed for
each mouse. Survival curves were plotted for the mutant strains
and compared to that of the wild-type control. Two mutants with
STM scores close to zero were indistinguishable from wild-type
in these survival curves (Figure 2D). Four mutants with STM
scores significantly below zero were attenuated for virulence
(Figure 2E) with the degree of attenuation closely correlated
with the magnitude of the STM defect. Interestingly, a mutant
with an STM score significantly above zero (zap103D) was
hypervirulent (Figure 2E). Together, these studies suggest that
the STM assay is a sensitive and specific measure for infectivity
and that in this pulmonary infection model of cryptococcosis,
altered infectivity correlates well with altered virulence.
Based on these results, we chose STM scores of < 2.5 and
> +2.5 as the cutoff points for reduced infectivity and increased
infectivity, respectively. Application of these criteria to our data
yielded 164 (15%) mutants in the former category and 33 (3%)
in the latter.
Systematic In Vitro Phenotyping of the Deletion
Collection Identifies Mutants Defective
in Known Virulence Attributes
To complement the in vivo STM screen, we systematically as-
sayed the deletion collection in vitro for three known virulence-
associated phenotypes: (1) growth in minimal medium at 37C,
(2) melanization, and (3) synthesis of the polysaccharide capsule.
A high-throughput, 96-well format assay was developed to
measure the growth of eachmutant in synthetic minimal medium
(YNB) at 37C. As expected, a large overlap existed between
mutants that displayed poor growth at 37C and mutants with
STM defects (p = 8.2E-30) (Figure 2F). Using hypergeometric
distribution analysis, we determined that mutants that displayed
growth scores greater than 0.5 did not show a significant
enrichment for mutants with virulence phenotypes (p > 0.01)
(Figure S1); thus, we used a growth score of 0.5 as a cutoff
for determining which mutants were categorized as having sig-
nificant growth defects. Some mutants displayed severe growth
defects but not STM defects. We attributed at least a portion of
this inconsistency to the fact that minimal medium does not
perfectly mimic the nutritional environment found within theFigure 2. In Vivo Signature-Tagged Mutagenesis Analysis of Gene Deletions
(A) Mutants were pooled in groups of 48 and used to intranasally infect three mice. Quantitative PCR with signature tag-specific primers was used to calculate
a signature-tagged mutagenesis (STM) score for each mutant. Red-dotted lines indicate cutoffs used to identify STM phenotypes of interest.
(B) 104 mutants assayed by STM were sorted into new pools containing different competitors and retested. Original STM scores show a strong correlation with
repooled STM scores.
(C) The frequencies of STM scores observed in this screen were plotted for both the deletion collection and the sxi1D control strains. Red-dotted lines indicate
cutoffs used to identify STM phenotypes of interest. Indicated below are the STM scores of gene knockouts in the collection previously reported to have (red) or
not to have (black) virulence defects.
(D and E) Survival curve analyses of mice infected with individual strains demonstrate the correlation between STM phenotypes and virulence phenotypes. Both
hypovirulent and hypervirulent strains were accurately identified by STM. P-values indicate the significance of the virulence phenotype.
(F) Shown is the distribution of in vivo and in vitro phenotypes in the deletion collection. Significant overlaps were seen between mutants with defects in the three
virulence attributes and mutants with in vivo infectivity defects.Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 177
host. For example, mutants in peroxisome function (pex1D and
pex6D) have been shown previously to have normal virulence
despite being unable to grow on YNB with glucose as the sole
carbon source (Idnurm et al., 2007).
To identify mutants defective in melanin synthesis, we grew
the deletion collection on agar plates containing L-DOPA
(a diphenolic substrate). Wild-type cells turned dark brown
over 2–3 days as they synthesized and accumulated melanin.
Thirty-eight deletion mutants displayed decreased levels of
melanization compared to wild-type, including known melanin
mutants such as lac1D, cac1D, and pka1D (Alspaugh et al.,
2002; D’Souza et al., 2001; Noverr et al., 2004). As noted above,
the lac1D mutant (which lacks the laccase primarily responsible
for melanin synthesis) has late defects in dissemination from the
lungs but grows normally in lung tissue (Noverr et al., 2004); as
such, it was not identified by the STM screen. Likewise, a mutant
containing a deletion of the secondC. neoformans laccase gene,
LAC2, as well as a double knockout mutant, lac1D lac2D, did not
display STM phenotypes (Table S2). This is consistent with mel-
anization playing a role in dissemination, but not lung infectivity.
Thus, we were surprised to note that overall there was a signifi-
cant overlap between mutants with melanization defects and
those with STM defects in the lungs (Figure 2F). This association
remained significant (p = 1.4E-11) even after excluding mutants
with growth defects from the analysis. Given that the laccases
were dispensable for lung infection, additional defects beyond
poor pigment production must be proposed in this subset of
melanin-defective mutants to account for their lung infectivity
defects. These deficits may affect coregulated pathways that
function independently of and/or redundantly with melanization
to promote lung proliferation.
To identify mutants defective in polysaccharide capsule for-
mation, we screened for mutants with a dry colony appearance
on rich medium (YPAD) agar plates. A dry colony morphology
is characteristic of most known C. neoformansmutants with ab-
sent or greatly reduced amounts of capsule (Griffith et al., 2004;
Moyrand et al., 2004; Moyrand and Janbon, 2004). Using this
simple assay, we identified eleven potentially capsule-defective
mutants including six strains (cap59D, cap64D, cap60D,
cap10D, cas35D, and nrg1D) that contain deletions in genes
previously implicated in capsule synthesis (Cramer et al., 2006;
Moyrand et al., 2004; Okabayashi et al., 2007). In addition,
PBX1 and PBX2 were first identified in this screen; deletion of
PBX1 or PBX2 affects the fidelity of polysaccharide synthesis
and their detailed analysis has been described elsewhere (Liu
et al., 2007). As expected, all mutants with dry colony morphol-
ogies also had STMdefects, consistent with thewell-established
importance of the capsule for causing disease (Figure 2F).
Certain mutants, such as pka1D and cac1D, are known to
produce reduced or structurally-altered capsules (Alspaugh
et al., 2002; D’Souza et al., 2001), but do not have dry colony
morphologies. To identify this class ofmutant, we tested a subset
of mutants in the collection for the ability to induce capsule for-
mation using an India ink assay. This stain yields a characteristic
halo around cells with enlarged capsules (we note this analysis
does not rule out subtle capsule structure defects that would
otherwise only be detectable by NMR analysis). We tested
82 mutants that displayed melanin and/or STM defects but178 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.normal colony morphology. Only one mutant, containing a dele-
tion of GAT201 (which encodes a GATA-family zinc finger DNA-
binding transcriptional regulator, Figure S2), produced no visible
capsule by India ink staining under capsule-inducing conditions
(Figure 4C). Further investigation of the role of GAT201 in
C. neoformans pathogenesis is described below.
In total, among 164 mutants with STM defects, 85 also had
defects in growth at 37C, polysaccharide capsule formation,
and/ormelanization. The remaining 79mutants appeared normal
in all three in vitro assays (Figure 2F). To verify that the observed
phenotypes were linked to the targeted deletions, we recon-
structed 107 deletion strains and retested for the original pheno-
type: 5 of 5 reconstructed strains reproduced the original capsule
phenotype; 33 of 35 reproduced the original melanin phenotype;
53 of 67 reproduced an STM score significantly below zero; and
8 of 11 reproduced an STM score significantly above zero (Fig-
ure S3). The results overall indicate strong linkage between the
targeted mutation and the observed phenotypes. Slightly higher
variability in reproduction of STM phenotypes may reflect both
higher variability of the assayand thepotential for a larger number
of unlinked mutations to affect this phenotype.
Novel Melanin and Capsule Genes
Thirty-three novel genes that regulate melanization and five
novel genes that regulate capsule formation were identified
and verified by knockout reconstruction and retesting (Figure 3,
Table 1). As described previously (Chow et al., 2007), gene
names were assigned based on homology to known S. cerevi-
siae genes when available. Four melanin genes and one capsule
gene could not be named using this approach and, instead, were
designated MLN1-MLN4 and CPL1 respectively. The melanin
and capsule genes identified in these screens implicate a number
of novel pathways in the regulation of these two virulence attri-
butes. For example, mutants that lack the transcription factor
Rim101 and its predicted upstream regulator Rim20 both display
melanization defects (Figure S3). Similarly, deletion of compo-
nents of the Set3 deacetylase complex resulted in significantly
larger capsules compared to wild-type as well as defects in
melanization (Figures S3 and S4).
Novel Infectivity Genes
A particularly interesting category of mutants identified in these
screens had defects in lung infectivity but were normal for
growth, capsule, and melanin. Forty of these mutants were ver-
ified by knockout reconstruction and retesting using the STM as-
say (Figure 3, Table 2). Again, gene names were assigned based
on homology to known S. cerevisiae genes when available.
Fifteen unnamed genes were designated LIV1-LIV15 (Lung
InfectiVity).
In addition to capsule, melanin, and growth, a number of other
less-studied factors have been implicated in C. neoformans
virulence based on genetic studies. These include urease, alter-
native oxidase, phospholipase, reductive iron uptake, glucosyl-
ceramide synthesis, and resistance to nitrogen and oxygen
species (Akhter et al., 2003; Cox et al., 2003, 2001, 2000; de
Jesus-Berrios et al., 2003; Jung et al., 2008; Shea et al., 2006).
In most cases, mutants in these pathways display growth de-
fects on certain media. For example, mutants lacking the
Figure 3. Proteins Identified in This Work That Regulate Capsule Formation, Melanization, and/or Infectivity
Factors previously reported to affect these phenotypes and factors that affect growth in YNB are not included. Proteins predicted to encode signal peptides are
outlined in red. The relationships between melanization, dissemination, and lung infectivity are discussed in the text.phospholipase gene (PLB1) are sensitive to SDS (Siafakas et al.,
2007), mutants lacking the flavohemoglobin gene (FHB1) are
sensitive to acidified nitrite, and mutants lacking the alternative
oxidase gene (AOX1) are sensitive to potassium cyanide
(KCN). Thus, in order to identify potential roles for these infectiv-
ity genes, we systematically tested the 40 mutants described
above for growth on five media conditions as well as for urease
activity using an enzymatic assay. This analysis revealed five
mutants with sensitivity to acidified nitrite, two with sensitivity
to SDS, and two with sensitivity to KCN (Table 2, Figures S5–
S7). In contrast, none of the mutants displayed decreased
growth in pH 4 media (Figure S5) or in low ferrous iron conditions
(Figure S8) and none of the mutants displayed a defect in urease
activity (Figures S9).
Two of the mutants that displayed increased sensitivity to
acidified nitrite contain deletions of DNA repair genes (rad54D
and rad23D), suggesting that unrepaired DNA damage, perhaps
via free radical attack by phagocytes, can be deleterious to
infection (Figure S5). Notably, a mutant containing a deletion of
LIV8, which encodes an RGS (Regulator of G protein Signaling)
domain, was exquisitely sensitive to acidified nitrite, SDS, and
KCN (Figures S5–S7). We note that since these media assays
are relatively nonspecific, the sensitivities observed may or
may not explain the virulence defects of particular mutants. For
example, a mutant containing a deletion of the virulence gene
SRE1, which has been shown to be involved in ergosterol
biosynthesis (Chang et al., 2007; Chun et al., 2007), displayed
sensitivity to both SDS and KCN (Figures S6 and S7).
Nonetheless, the 33 mutants that did not display phenotypes
in any of these in vitro assays represent the genes that are the
strongest candidates for novel C. neoformans virulence factors.
Seven genes in this category encode predicted sequence-spe-cific transcription factors. Another five genes encode factors
likely involved in chromatin regulation. Of particular note, three
genes encode factors with strong homology to proteins previ-
ously implicated in pathogenesis or regulation of the human
immune response (Figure 3, Table 2). LIV5 encodes a protein
homologous to one required for pathogenesis by the plant fungal
pathogen Magnaporthe grisea (Fujimoto et al., 2002). LIV7
encodes a putative secreted protein that is homologous to a
human protein induced by lipopolysaccharide. Finally, LIV6
encodes a protein highly homologous to the human T cell immu-
nomodulatory protein (TIP). Secreted TIP has been shown to
directly regulate cytokine production by T cells (Fiscella et al.,
2003). Protein structure prediction indicated that Liv6 contains
FG-GAP repeats, which are commonly found in alpha integrins,
as well as a signal peptide sequence, suggesting that it may
be secreted (Figure S2). Deletion of LIV5 and LIV6 were con-
firmed to result in virulence defects by survival curve analysis
(Figures 2E and S10).
Wealso identifiedmutants that reproducibly showedsignificant
increases in the STM assay. Eight mutants were confirmed by
knockout reconstruction and retesting to display enhanced colo-
nization of lung tissue (Table 2). These include deletions of genes
encoding two members of Rho signaling pathways (RGD1 and
RHO104), two kinases (RCK2 andKSP1), and a transcription fac-
tor (ZAP103). One unnamed gene was designated LIV16. Dele-
tions of ZAP103 and RGD1were confirmed to result in increased
virulence by survival curve analysis (Figures 2E and S10).
Gat201: A Key Regulator of Virulence and
Capsule-Independent Antiphagocytic Mechanisms
Among mutants with normal growth at 37C, the strain contain-
ing a deletion of GAT201 exhibited the largest decrease in theCell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 179
Table 1. Novel Capsule and Melanin Mutants
Gene Deletion Phenotype
KO# Gene Name Broad Annotation Description STM Score Growth Score Capsule Melanin
Capsule
Transcription
D429 GAT201 CNAG_01551 GATA family DNA-binding regulator 18.3Y* 0.18 - ++
D226 SSN801 CNAG_00440 Cyclin subunit of Mediator subcomplex 1.4 0.18 ++ ++
Chromatin
D110 HOS2 CNAG_05563 Class II HDAC; component of Set3
complex in S. cerevisiae
16.1Y 1.24Y ++ -
D1487 SET302 CNAG_06591 SET domain protein; homolog of
S. cerevisiae Set3
10.9Y 0.86Y ++ -
Putative secreted proteins
D667 CPL1 CNAG_02797y Potential secreted protein of unknown
function
5.3Y* 0.04 - +
Melanin
Transcription
D1248 ZAP104 CNAG_05392 Zinc finger DNA-binding regulator 7.1Y* 0.06 + -
D1512 MBP102 CNAG_06721 APSES family DNA-binding regulator 3.5Y 0.08 + -
D528 NHP6B02 CNAG_02115 Nonhistone chromosomal protein 0.9 1.86Y + +/
D1218 MLN1 CNAG_04837 bHLH family DNA-binding regulator 0.3 0.04 + -
D228 NHP6B01 CNAG_00445 Nonhistone chromosomal protein 1.1 0.00 + -
D356 PAN1 CNAG_01173 LAG1 family DNA-binding regulator 1.4 0.40 + -
D1258 RIM101 CNAG_05431 Zn finger DNA-binding regulator
regulated by proteolysis
2.8[ 0.07 + -
Chromatin
D1498 RTF1 CNAG_06648 Component of PAF complex required
for histone H2B monoubiquitination
12.7Y 1.66Y + -
D78 SET202 CNAG_03188 Histone H3 lysine 36 methyltransferase 8.1Y 0.14 + -
D373 SET101 CNAG_01243 Histone H3 lysine 4 methyltransferase 4.5Y* 0.38 + +/
Protein sorting / Protein degradation
D282 DOA4 CNAG_00757 Ubiquitin hydrolase 15.6Y 0.06 + -
D1250 VAM6 CNAG_05395 Vacuolar membrane fusion factor 14.3Y 0.61Y + -
D1222 VPS25 CNAG_04863 ESCRT-II Complex subunit 13.8Y 0.06 + -
D1314 UBP14 CNAG_05708 Ubiquitin carboxyl-terminal hydrolase 12.3Y 0.27 + +/
D454 CSN1201 CNAG_01697 COP9 signalosome subunit 12; PINT
domain
8.9Y 0.58Y + +/
D936 CSN7 CNAG_04177 COP9 signalosome subunit 7; PINT domain 1.7 0.07 + +/
D598 CSN1 CNAG_02513 COP9 signalosome subunit 1; PINT domain 1.1 0.16 + +/
D737 CSN4 CNAG_03151 COP9 signalosome subunit 4; PINT domain 0.2 0.00 + +/
D1349 HSE102 CNAG_05882 Class E VPS factor involved in endosomal
sorting
0.2 0.00 + -
D671 RPS3102 CNAG_02827 NEDD8 ubiquitin-like protein that
regulates Cullins
4.1[ 1.68Y + -
Signaling
D245 YCK2 CNAG_00556 Casein kinase homolog involved in
endocytosis
15.4Y 0.44 + -
D1476 SNF102 CNAG_06552 AMP-activated kinase; ortholog of
S. cerevisiae Snf1
15.0Y* 0.34 + -
D731 CHO2 CNAG_03139 Putative protein-S-isoprenylcysteine
methyltransferase
12.3Y 0.27 + -
D221 CDC2801 CNAG_00415 Cyclin-dependent kinase of PITSLRE
subfamily
9.9Y 0.11 + +/180 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.
Table 1. Continued
Gene Deletion Phenotype
KO# Gene Name Broad Annotation Description STM Score Growth Score Capsule Melanin
D825 RIM20 CNAG_03582 ESCRT-III-associated regulator of Rim101 0.3 0.09 + -
Nuclear pore
D891 NUP75 CNAG_03917 Nuclear pore protein homologous to human
Nup75
14.2Y 1.83Y + +/
Unknown function
D1408 MLN2 CNAG_06224 CS domain protein of unknown function 1.4 1.24Y + -
D1453 MLN3 CNAG_06430 Mus7 domain-containing protein
conserved in fungi
1.6 0.78Y + +/
D445 MLN4 CNAG_01644 Protein of unknown function;
C. neoformans-specific
1.4 0.18 + -
Genes identified in this work that regulate capsule formation, melanization, and/or infectivity. Previously characterized genes can be found in Table S2.
Down arrows (Y) indicate significant decreases compared towild-type. Up arrows ([) indicate significant increases compared towild-type. Asterisks (*)
indicate that the STM phenotype was verified in a reconstructed knockout strain. Crosses (y) indicate gene models that are predicted to encode signal
peptides. These mutants were tested for six additional phenotypes: decreased urease activity and sensitivity to acidified nitrite (NO), SDS, potassium
cyanide (KCN) (pH 4), and low iron.STM screen (STM score = 18.3). Indeed, the gat201D mutant
strain was avirulent in monotypic infection of mice using our
standard inoculum (Figure 4A). This mutant was chosen for
further investigation.
As described above, capsules of gat201D cells could not be
visualized by India ink staining under capsule-inducing condi-
tions (Figure 4B). However, amore sensitive assay using amono-
clonal antibody to stain the main capsular polysaccharide,
glucoronoxylomannan, detected capsule polysaccharide on
the cell surface of gat201D cells (Figure 5B). These data suggest
GAT201 is not required for production of basal levels of capsule
polysaccharide but is needed for proper induction of large
capsules. gat201D cells were also hypermelanized when grown
on L-DOPA plates (Figure 4C). Previously-identified hypermelan-
ized mutants have been associated with both increased and
decreased virulence and often display additional phenotypes
such as altered capsule production (Bahn et al., 2005; Wang
et al., 2004). Similarly, our studies indicate GAT201 participates
directly or indirectly in the regulation of both capsule induction
and melanization.
Consistent with this notion, overexpression ofGAT201 in wild-
type cells using the promoter of a constitutive ribosomal protein
gene (pRPL2b) was sufficient to induce large capsule formation,
even in normally non-inducing growth conditions (Figures 4B and
S11). As shown in Figure 4C, the pRPL2b::GAT201 strain also
displayed a slight melanization defect. The pRPL2b::GAT201
strain was hypervirulent in mice after monotypic intranasal infec-
tion (Figure 4A), demonstrating that overexpression ofGAT201 is
sufficient to activate key virulence pathways. A reconstructed
gat201D strain recapitulated the phenotypes of the original
gat201D strain in these assays (Figures 4A–4C).
Whole-genome, microarray-based expression profiling of the
pRPL2b::GAT201 strain identified 543 genes that were signifi-
cantly upregulated and 24 genes that were significantly downre-
gulated compared to a wild-type strain (Figure 4D). Consistent
with the enhanced nutritional and metabolic requirements
necessary for ectopic polysaccharide capsule formation, theinduced set contained a substantial number of genes encoding
proteins involved in carbohydrate regulation, including sugar
transporters (40 genes), glycosyl hydrolases (8 genes), and gly-
cosyl transferases (5 genes). In addition, twenty-five genes that
encode DNA-binding transcription factors were upregulated in
the pRPL2b::GAT201 strain, suggesting that Gat201 exerts at
least a portion of its effects by activating the expression of other
transcription factors. Using a previously described annotation
database (Chow et al., 2007), we identified C. neoformans genes
that do not have homologs in nine sequenced ascomycetes and
two sequenced basidiomycetes. Over 29% of Gat201-upregu-
lated genes (159 genes) fall into this C. neoformans-specific
gene class, which represents a significant enrichment over their
general representation on the microarray (p = 1.2E-35). Sixteen
of these genes are predicted to produce proteins with signal
sequences but no transmembrane domain; these potential
secreted effectors include all members of a unique four-gene
family (CNF2230, CNF2240, CNF2250, and CND5620).
To further probe the role of Gat201 in virulence, we examined
the interaction of gat201D cells with RAW264.7 mouse macro-
phages. Phagocytic cells play a central role in the host immune
response against C. neoformans, and the ability of C. neofor-
mans to avoid phagocytosis and killing by these cells is crucial
to pathogenesis (Del Poeta, 2004). In contrast to most fungi,
such as C. albicans and S. cerevisiae, wild-type C. neoformans
undergoes negligible phagocytosis by cultured macrophages in
the absence of opsonizing antibodies or complement (Kozel and
Mastroianni, 1976). The antiphagocytic properties of C. neofor-
mans have largely been attributed to the polysaccharide
capsule (Del Poeta, 2004). We recapitulated these results with
wild-type C. neoformans, observing both robust induction of
capsule and a very low rate of phagocytosis after 24 hr of cocul-
turing with RAW264.7 macrophages (<2% of macrophages
contained internalized wild-type C. neoformans, Figures 5A,
5B, and S12). Deletion of the capsule-associated genes
CAP10, CAP60, or CAP64 resulted in approximately a three-
to seven-fold increase in the number of macrophagesCell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 181
Table 2. Infectivity Mutants without Defects in Capsule Formation, Melanization, or Growth in YNB
Gene Deletion Phenotype
KO# Gene Name Broad Annotation Description STM Score Growth Score Additional Phenotypes
Decreased Infectivity (STM Score < 2.5)
Transcription
D883 PDR802 CNAG_03894 Binuclear cluster DNA-binding regulator 7.2Y* 0.08 None detected
D231 LIV1 CNAG_00460 bHLH family DNA-binding regulator 6.1Y* 0.35 None detected
D725 HCM1 CNAG_03116 Forkhead DNA-binding regulator 4.2Y* 0.46 None detected
D140 SNT1 CNAG_00051 SANT domain protein related to
human NCOR corepressor subunit
4.0Y* 0.10 None detected
D177 LIV2 CNAG_00201 LAG1 family DNA-binding regulator 3.9Y* 0.06 None detected
D1338 LIV3 CNAG_05835 WOR1 family DNA-binding regulator 3.7Y* 0.03 None detected
D1420 LIV4 CNAG_03116 Myb family DNA-binding regulator 2.5Y* 0.03 None detected
Chromatin
D111 RPD304 CNAG_05690 Class II histone deacetylase 11.5Y* 0.30 None detected
D1296 RPH1 CNAG_05622 Histone H3 lysine 36 demethylase 8.0Y* 0.25 None detected
D933 HIRA CNAG_04158 Histone chaperone 6.7Y* 0.15 Inc. sensitivity to NO
D790 SPP101 CNAG_03406 PHD domain protein of unknown
function
6.1Y* 0.09 None detected
D1428 SAS3 CNAG_06322 Histone acetyltransferase 4.4Y* 0.18 None detected
D62 HST302 CNAG_02085 Homolog of Sir2; Class III histone
deacetylase
2.8Y* 0.11 None detected
Protein sorting/Protein degradation
D1266 HRD1 CNAG_05469 Transmembrane ubiquitin ligase required
for ER-associated degradation
8.0Y* 0.38 Inc. sensitivity to NO
D317 UBA4 CNAG_00986 Urm1 activating protein 6.0Y* 0.20 None detected
D399 RMD5 CNAG_01350 Ubiquitin ligase of unknown function 4.3Y* 0.02 None detected
D729 CUL3 CNAG_03138 Cullin subunit of SCF-like ubiquitin ligase 3.6Y* 0.11 None detected
D1166 UBC8 CNAG_04611 Ubiquitin conjugating enzyme 3.5Y* 0.16 None detected
D1278 JJJ1 CNAG_05538 DnaJ-like cochaperone; contains U1
snRNA-type Zn finger
3.4Y* 0.11 None detected
DNA Repair
D352 RAD54 CNAG_01163 SWI/SNF family ATPase that promotes
recombinational DNA repair
9.3Y* 0.49 Inc. sensitivity to NO
D288 RAD23 CNAG_00772 Ubiquitin-binding protein required for
nucleotide excision repair
7.6Y* 0.09 Inc. sensitivity to NO
D832 YKU80 CNAG_03637 Double strand break repair factor and
silencing regulator
4.9Y* 0.04 None detected
D632 RAD502 CNAG_02630 SWI/SNF family ATPase that promotes
recombinational DNA repair
2.7Y* 0.04 None detected
D855 RINT1 CNAG_03760 Rad50-interacting protein implicated in
DNA repair
2.5Y* 0.01 Inc. sensitivity to KCN
Pathogenesis/Immunity
D576 LIV5 CNAG_02409 TB2/DP1 family member homologous
to M. grisea pathogenicity protein
12.6Y* 0.09 None detected
D166 LIV6 CNAG_00170y Related to human T cell immunomodulatory
protein; FG-GAP repeats
6.2Y* 0.14 None detected
D1466 LIV7 CNAG_06464y Protein of unknown function; human
homolog is LPS-inducible
3.2Y* 0.17 None detected
Signaling
D972 HSV2 CNAG_04371 WD40 protein related to 3-phosphorylated
inositide-binding protein
15.9Y* 0.18 None detected
D280 HRK1 CNAG_00745 Protein kinase; S. cerevisiae ortholog
regulates metabolite transport
6.8Y* 0.14 Inc. sensitivity to SDS182 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.
Table 2. Continued
Gene Deletion Phenotype
KO# Gene Name Broad Annotation Description STM Score Growth Score Additional Phenotypes
D437 LIV8 CNAG_01611 RGS protein homolog - G protein GAP 2.7Y* 0.10 Inc. sensitivity to NO,
SDS, KCN
Unknown
D70 HOS4 CNAG_02727 Ankyrin repeat protein of unknown function 7.6Y* 0.09 None detected
D736 LIV9 CNAG_03149 RING and ubiquitin-binding protein
with BRAP2 domain
7.3Y* 0.04 None detected
D686 LIV10 CNAG_02930 DUF1765 domain protein of unknown
function
7.1Y* 0.19 None detected
D171 FYV10 CNAG_00181 LisH, CTLH domain protein of
unknown function
6.5Y* 0.06 None detected
D1256 LIV11 CNAG_05422 Protein of unknown function 5.0Y* 0.49 None detected
D1035 LIV12 CNAG_05105 Protein of unknown function 3.9Y* 0.11 None detected
D660 LIV13 CNAG_02753 UPF0121 domain protein of
unknown function
3.2Y* 0.34 None detected
D1448 LIV14 CNAG_06397 Protein of unknown function 2.9Y* 0.06 None detected
D1357 LIV15 CNAG_05934 Translin domain protein of
unknown function
2.8Y* 0.09 None detected
Transporter
D1091 ENA2 CNAG_00531 Sodium pump 11.1Y* 0.11 None detected
Increased Infectivity (STM Score > 2.5)
Transcription
D88 ZAP103 CNAG_04352 Zinc finger DNA-binding regulator 3.2[* 0.14
Signaling
D1340 RGD1 CNAG_05838 Rho GAP homolog 5.3[* 0.07
D1490 RHO104 CNAG_06606 Rho family GTPase 4.4[* 0.33
D1156 RCK2 CNAG_00130 Ca-CaM kinase homolog 3.7[* 0.03
D488 KSP1 CNAG_01905 Protein kinase 3.4[* 0.04
Cell wall
D61 BNI4 CNAG_02071 S. cerevisiae ortholog is a scaffold
protein involved in cell wall assembly
4.8[* 0.27
Actin-related
D359 LSB1 CNAG_01183 BAR-SH3 domain; S. cerevisiae
homolog binds actin nucleator WASP
3.6[* 0.11
Unknown
D1179 LIV16 CNAG_07193y Conserved protein of unknown function 3.8[* 0.05
Genes identified in this work that regulate capsule formation, melanization, and/or infectivity. Previously characterized genes can be found in Table S2.
Down arrows (Y) indicate significant decreases compared towild-type. Up arrows ([) indicate significant increases compared towild-type. Asterisks (*)
indicate that the STM phenotype was verified in a reconstructed knockout strain. Crosses (y) indicate gene models that are predicted to encode signal
peptides. This table includes only infectivity mutants that did not display defects in capsule formation, melanization, or growth in YNB. These mutants
were tested for six additional phenotypes: decreased urease activity and sensitivity to acidified nitrite (NO), SDS, potassium cyanide (KCN) (pH 4), and
low iron.containing C. neoformans (4%–14%). As previously reported
(Moyrand and Janbon, 2004), cap10D, cap60D, and cap64D
mutants had no detectable capsular material, either by antibody
or India ink staining (Figure 5C). Unexpectedly, a dramatic in-
crease in the amount of phagocytosis was seen when
RAW264.7 macrophages were cocultured with gat201D cells;
66% of macrophages contained internalized C. neoformans af-
ter 24 hr (Figures 5A and 5B). Since gat201D mutants were
phagocytosed more readily than CAP gene mutants, yet dis-
played a weaker capsule defect, the phagocytosis phenotypeof gat201D cells could not easily be explained by its hypocapsu-
lar phenotype. To examine the role of GAT201 in the absence of
capsule, we asked whether double mutants lacking both
GAT201 and one of the CAP genes were phagocytosed to
a greater extent than the CAP gene single mutants. Strikingly,
we found this to be the case: high levels of phagocytosis were
seen in gat201D cap10D (47%), gat201D cap60D (57%), and
gat201D cap64D (52%) double mutant strains (Figure 5B).
Unlike gat201D single mutants, these double mutant strains
had no detectable capsules by antibody or India ink stainingCell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 183
Figure 4. Gat201 Is a Regulator of Multiple Virulence Pathways
(A) gat201Dmutant strains (two independent knockout strains) were avirulent during monotypic infection and aGAT201 overexpression strain was hypervirulent.
(B) gat201Dmutant strains did not induce an observable capsule by India ink staining in capsule-inducing conditions, though capsule polysaccharide on the cell
surface was detected by antibody staining (Figure 5B). GAT201 overexpression resulted in ectopic capsule formation in normally non-inducing conditions.
Quantification of capsule size is shown in Figure S11.
(C) gat201D mutants strains showed increased melanization while a GAT201 overexpression strain showed decreased melanization.
(D) Transcriptional profiles of pRPL2b::GAT201 and wild-type grown at 37C in minimal medium were compared using whole-genome microarrays. Values
represent the average of four microarrays.and displayed clumpy phenotypes characteristic of cap10D,
cap60D, and cap64D single mutants (Figure 5C), indicating
that the capsule is not the basis for the difference in phagocyto-
sis between gat201D and the CAP mutants.
DISCUSSION
The incidence of invasive fungal infections in humans has risen
dramatically in the last two decades (Warnock, 2006), yet our
understanding of the molecular mechanisms relevant to fungal184 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.pathogenesis remains limited. The analysis of theC. neoformans
gene deletion collection described here demonstrates the po-
tential for harnessing genome sequencing efforts to implement
systematic approaches for identifying and dissecting fungal vir-
ulence mechanisms. Since biolistic gene knockout methods for
C. neoformanswere introduced in 1993,190 targeted deletions
have been reported in the literature (Table S1 summarizes the
phenotypes of previously-described gene deletions). We report
the construction and analysis of 1201 targeted gene deletion
strains, significantly extending the genetic resources for this
Figure 5. Gat201 Inhibits Phagocytosis Independent of Capsule
(A and B) Phagocytosis of untreated wild-type (WT) and gat201D cells by RAW264.7 macrophages was measured in both WT and capsule-deficient back-
grounds. The percentage of macrophages containing internalized C. neoformans cells was determined after 24 hr of coincubation. Data are represented as
mean ± SD from triplicate wells.
(C) GXM can be detected on the cell surface of gat201D cells, but not in single and double mutants containing deletions of CAP genes.
(D) Model of GAT201 regulation of phagocytosis. ‘‘X’’ represents a novel capsule-independent mechanism for inhibiting phagocytosis by macrophages.pathogen. Systematic profiling of the deletion collection yielded
a number of insights into C. neoformans virulence:
(1) Melanization: By identifying and analyzing numerous novel
factors required for melanization, we obtained strong evidence
that virulence and melanization are coregulated, but that the
lung proliferation defects observed in a large subset of melanin
mutants result from defects beyond poor melanization.
(2) Polysaccharide capsule:We confirmed the role of the poly-
saccharide capsule in virulence. Our screen identified four novel
hypocapsular mutants, all of which displayed defects in infec-
tion. Gat201, following Nrg1 (Cramer et al., 2006), is the second
DNA-binding transcription factor found to regulate capsule for-
mation. Gat201 is normally limiting for synthesis of this virulence
factor since overexpression of GAT201 is sufficient to induce
capsule synthesis under classically non-inducing conditions.
As Gat201 also controls melanization, inhibition of phagocytosis,
and virulence, it appears to be a central point of regulation for
cryptococcal pathogenesis.
(3) Capsule-independent antiphagocytic pathways: The anti-
phagocytic properties of C. neoformans have largely been
attributed to its polysaccharide capsule (Del Poeta, 2004). Our
analysis of the Gat201 transcriptional regulator has identifieda previously unsuspected capsule-independent mechanism of
antiphagocytosis since deletion of GAT201, both in wild-type
and capsule-deficient genetic backgrounds, resulted in a dra-
matic increase in phagocytosis of untreated C. neoformans by
macrophages. SomeCAPmutantsdoproduce theminor capsule
polysaccharide, galactoxylomannan (GalXM), which is detect-
able in culture supernatant (Vaishnav et al., 1998). Whether
GAT201 functions by controlling the synthesis of GalXM, protein
factors, and/or lipids, andwhether the effect seen ingat201Dmu-
tants is due to the lack of an antiphagocytic factor or thepresence
of a pro-phagocytic factor remain unclear. Transcriptional profil-
ing of a GAT201 overexpression strain detected a significant en-
richment (p = 1.2E-35) for transcripts ofC. neoformansgenes that
are not found in other sequenced fungi including a number of pre-
dicted secreted proteins—some of these could contribute to C.
neoformans-specific virulencepathways, includingones involved
in inhibiting phagocytosis by macrophages. Finally, 25 genes
encoding DNA-binding transcription factors were upregulated
in the overexpression strain, suggesting that Gat201may control
a large, virulence-associated transcriptional regulatory circuit.
(4) Potential novel virulence pathways: Molecular studies of
C. neoformans virulence have focused primarily on the regulationCell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc. 185
of the capsule and melanization. The discovery of 48 previously
undescribed genes (40 mutants with decreased infectivity,
8 mutants with increased infectivity), that affect proliferation in
lung tissue, but not capsule, growth or melanin, strongly sug-
gests the existence of additional unknown virulence mecha-
nisms and provides tools for their identification. In principle,
these genes could code for (1) regulators of novel virulence path-
ways or (2) direct effectors of virulence. Potential regulators
include seven predicted transcription factors, whose targets
presumably include pathogenesis factors. Possible direct effec-
tors of virulence include three factors with homology to proteins
previously linked to pathogenesis and/or immune modulation
(Liv5, Liv6 and Liv7). A substantial number of proteins required
for infectivity were identified whose function cannot be inferred
from sequence relationships, indicating that novel molecular
functions yet to be assigned to specific proteins in any organism
are likely to play a role in fungal virulence. Taken together, the
identification and categorization of infectivity mutants in a
large deletion library highlight the advantages of using a multi-
pronged, systematic genetic analysis to dissect pathogenic
mechanisms.
EXPERIMENTAL PROCEDURES
Generation of Gene Deletion Strains
Cryptococcus neoformans var. grubii serotype A clinical strain H99 (a gift from
J. Lodge) was used as wild-type. A previously described strategy for gene de-
letion (Chun et al., 2007) utilizing overlap fusion PCR and biolistic techniques
was used to generate knockout strains (see Supplementary Materials). Details
on the deletion collection including the targeted regions in each mutant can be
found in Table S4.
Signature-Tagged Mutagenesis
Groups of 48 C. neoformans deletion strains were individually grown in liquid
YPAD and combined into a single pool. These pooled inocula were used to in-
tranasally infect three mice each. Three aliquots of each inoculum (5 3 105
cells) were also plated on Sabouraud agar plates containing 40 mg/ml gentami-
cin and 50 mg/ml carbenicillin. Genomic DNA (Input DNA) was purified inde-
pendently from each plate using hexadecyltrimethyl ammonium bromide
(CTAB, Sigma). Infected mice were monitored and sacrificed at the disease
endpoint. Lungs were removed and homogenized in 5ml sterile PBS. Serial di-
lutions of each organ sample were plated on Sabouraud agar plates containing
40 mg/ml gentamicin and 50 mg/ml carbenicillin. Genomic DNA (Output DNA)
from each set of lungs was purified using CTAB.
The amounts of each signature tag in a genomic DNA prep were mea-
sured using 48 simultaneous quantitative PCR reactions. Each reaction
was identical except for a different tag-specific primer (Table S7). The
threshold cycle (Ct) was determined for each reaction and an STM score
was calculated for each mutant using a variation of the 2-DDCt method for
quantitation analysis (Livak and Schmittgen, 2001). STM scores from three
mice were averaged to determine a final STM score for each mutant. A de-
tailed description of this STM method can be found in the Supplemental
Data.
In Vitro Phenotyping
Polysaccharide capsule formation, melanin synthesis, urease activity, and
growth on acidified nitrite, SDS, potassium cyanide (pH 4), and low iron me-
dium were assayed using standard conditions (see Supplementary Materials).
Growth in minimal medium was quantified by measuring the change in optical
density at 600 nm (OD600) after 24 hr growth using an optical plate reader
(Molecular Devices). Growth scores were normalized to the median growth
in groups of 48 (see Supplemental Data).186 Cell 135, 174–188, October 3, 2008 ª2008 Elsevier Inc.Statistical Analysis
Significances of overlaps between STM, capsule, and melanin phenotypes
were measured using a hypergeometric test. Correlation of STM and growth
defects was analyzed bymeasuring enrichment for STMdefects in a 25mutant
moving average across growth scores using a hypergeometric test.
Significances of mutant STM scores were calculated by measuring the
divergence of a mutant STM score from the distribution of sxiD STM scores
using a z-score calculation. For retesting of STM phenotypes in reconstructed
knockouts, an STM score of 1.5 was used as a threshold for significance
(p < .001).
Survival curves were analyzed using the Kaplan-Meier method and log
rank test.
Macrophage Assays
To test for phagocytosis of untreatedC. neoformans, RAW264.7macrophages
(43 104 cells/well) were seeded in 96-well tissue culture-treated glass bottom
plates (Nunc) in DMEMmedia and allowed to adhere overnight.C. neoformans
cells from overnight cultures grown in liquid YPAD were washed three times
with PBS and then lightly sonicated using a Sonifer 450 equipped with a
microtip (Branson, two one-second pulses at a power setting of 2) to break
up any clumps of cells prior to incubation with macrophages. Sonication did
not affect the viability of cells and similar results were obtained in phagocytosis
assays that utilized wild-type and gat201D cells that were not sonicated
(Figure S13). The yeast cells were resuspended in PBS to a concentration of
107 cells/ml, and 10 ml (105 cells) were coincubated with RAW264.7 cells (in
200 ml fresh DMEM/well) for an MOI of 2:1. Following 24 hr of coincubation,
unphagocytosed C. neoformans cells were removed with three washes of
PBS, and yeast and macrophages were fixed with 1% formaldehyde/PBS.
Remaining extracellular yeast were labeled with a mixture of an anti-glucoron-
xylomannan antibody, mAb 339 (Belay et al., 1997), and an anti-beta-glucan
mouse monoclonal antibody (Biosupplies Australia) in PBS, a combination
which labels both encapsulated and acapsular strains. Following three washes
with PBS, the cells were then incubated with FITC-conjugated donkey
anti-mouse secondary antibody (Jackson ImmunoResearch) in PBS. Phago-
cytosis of C. neoformans was quantified on an Axiovert 200M (Zeiss)
microscope running Axiovision software. Percentage of macrophages with
phagocytosed yeast was determined by counting the number of macrophages
with internalized yeast (as defined by the absence of FITC-labeling). At least
200 macrophages were assayed per well, and each strain was tested in
triplicate.
Microarrays
Four replicate cultures each of H99 and pRPL2b::GAT201 were grown
overnight to saturation in YNB at 37C. Cultures were diluted to an OD600 of
0.1 in YNB (pre-warmed to 37C), grown to anOD600 of 1.0, and then harvested
by centrifugation and snap freezing. RNA isolation, array hybridizations, and
data analysis using SAM analysis were performed as previously described
(Chun et al., 2007, see Supplementary Materials). Microarray data can be
found at the Gene Expression Omnibus (GSE10750).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, thirteen figures, and seven tables and can be found
with this article online at http://www.cell.com/cgi/content/full/135/1/174/
DC1/.
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